DSIP

DSIP

2mg

$29.00

Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide (nine amino acids) known for promoting deep, restorative slow-wave sleep (delta waves) and regulating circadian rhythms. Primarily used in research for sleep disorders, stress reduction, and pain management, it is often administered via IV or subcutaneous injection to improve sleep quality without the dependency issues of traditional sedatives.

Key Aspects of DSIP

Sleep Promotion: Originally isolated from rabbit brains in 1977, it induces delta EEG activity, which is associated with deep stage 3 sleep, aiding recovery.
Stress Regulation: Studies suggest it can help normalize circadian rhythms and reduce stress-related hormonal imbalances by lowering cortisol levels.

Potential Therapeutic Uses: Research indicates potential in managing chronic pain, withdrawal syndromes, and alleviating anxiety or stress-related insomnia.

Mechanism: Unlike sedatives, DSIP does not cause unconsciousness but modulates neural pathways to enhance natural, deep sleep cycles.

Current Status: While utilized in integrative medicine, human clinical data is limited, and it is not FDA-approved for treating specific conditions.

Dosage & Administration: Traditional doses often involve (100 \mcg) via IV or subcutaneous injection.

Potential Side Effects & Considerations

Safety and Efficacy: While generally well-tolerated, some users may experience headaches.
Contraindications: Experts suggest avoiding DSIP if pregnant or breastfeeding, and it may not be suitable for those with a personal history of cancer.
Weak Evidence: Some studies suggest that the effects of DSIP on chronic insomnia, while present, may be weak, and further research is needed to determine its full efficacy